Back to search

University of Glasgow

Photodynamic Therapy in Cutaneous Malignancy

Abstract

dc:description.abstract

Introduction: The aim of this thesis was to critically evaluate the potential of photodynamic therapy (PDT), using a novel non-laser light source and a topically active photosensitizing agent, 5-aminolaevulinic acid (5-ALA), for use in the management of skin cancer. PDT primarily acts via the activation by visible light, of a photosensitizer located within the neoplastic tissue, to produce activated oxygen species, especially singlet oxygen, in order to promote tumour destruction. Lasers have been the usual source of irradiation in PDT although coherence of light is not required. Recent developments in light technology have enabled the production of a relatively inexpensive non-coherent light source of similar intensity and wavelength to laser. The development of a topically active agent, 5-aminolaevulinic acid (5-ALA), converted within cells to the active photosensitizer, protoporphyrin IX, can now avoid prolonged generalized photosensitivity reactions which limited the development of PDT as a practical clinical therapy. Published clinical data on ALA-PDT available at the commencement of this thesis related predominantly to the use of lasers in open studies, with short term follow-up. The potential of non-laser light had received only limited interest and no randomized comparison trials of PDT had been undertaken. (Abstract shortened by ProQuest.).

Degree

thesis:*
Level dc:type.qualificationlevel
MD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1998

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Morton, Colin Andrew

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Morton, Colin Andrew. Photodynamic Therapy in Cutaneous Malignancy. MD thesis, University of Glasgow, 1998.